On July 9th, Roche Diagnostics Asia-Pacific production base and R&D center built another new manufacturing building-System Reagent Manufacturing Base. It was officially completed in Suzhou Industrial Park. The total investment in the project is 390 million yuan.

On June 26, 2021, Shanghai, Sanyou Biopharmaceutical (Shanghai) Co., Ltd. announced the closing of series B financing. This financing round was co-led by LH Ventures and Montesy Investment and followed by Grand Mount Capital and Seeking Capital (an existing investor).

SpeeDx announced recentlythat it has raised a total of $15 million from a US investment group.The Sydney, Australia-based molecular diagnostics developer said it had raised up to $10 million in additional equity investment from US-based Nort

Thermo Fisher Scientific, the world leader in serving science, recently announced that it will be investing more than $50m (£39.8m) in its global bioproduction capabilities to provide additional capacity for manufacturing single-use bioproc